Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DRKS00012664Phase 4Recruiting
Phase 4, randomised, double-blind trial of prednisolone in tinnitus and idiopathic sudden sensorineural hearing loss (ISSNHL) (3 arms), sponsored by Universitätsklinik für Hals-, Nasen- und Ohrenheilkunde, Kopf- und Halschirurgie. Started Jun 2017; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on DRKS00012664.